Segment Data (Schedule of Segment Reporting Information by Business Segment) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016
Net sales		$ 793.9	$ 887.2	$ 2,429.3	$ 2,569.6
Operating income		120.7	147.7	323.0	455.2
Intangible asset amortization		(173.2)	(175.9)	(523.0)	(526.7)
Restructuring and related charges, net		(15.5)	(8.7)	(35.7)	(34.0)
Non-restructuring impairment charges		0.0	0.0	0.0	(16.9)
Specialty Brands
Restructuring and related charges, net		(14.6)	(4.9)	(24.1)	(21.7)
Specialty Generics
Restructuring and related charges, net		0.6	(0.7)	(7.3)	(2.3)
Operating Segments
Net sales		780.5	872.9	2,386.8	2,525.0
Operating income		357.0	398.0	1,045.6	1,158.0
Operating Segments | Specialty Brands
Net sales		591.4	633.1	1,743.1	1,757.4
Operating income		316.6	334.1	865.7	897.1
Operating Segments | Specialty Generics
Net sales		189.1	239.8	643.7	767.6
Operating income		40.4	63.9	179.9	260.9
Corporate, Non-Segment
Net sales	[1]	13.4	14.3	42.5	44.6
Corporate and unallocated expenses	[2]	(47.6)	(65.7)	(163.9)	(125.2)
Intangible asset amortization		(173.2)	(175.9)	(523.0)	(526.7)
Restructuring and related charges, net	[3]	(15.5)	(8.7)	(35.7)	(34.0)
Non-restructuring impairment charges		$ 0.0	$ 0.0	$ 0.0	$ 16.9

[1] Represents net sales under an ongoing supply agreement with the acquirer of the CMDS business.

[2] Includes administration expenses and certain compensation, legal, environmental and other costs not charged to the Company's reportable segments.

[3] Includes restructuring-related accelerated depreciation.